机译:Olaparib与紫杉醇组合在患有先进的胃癌患者中,患有先进的胃癌(黄金):双盲,随机,安慰剂控制,第3期试验
Department of Internal Medicine Cancer Research Institute Seoul National University College of;
Sun Yat-sen University Cancer Center;
The Cancer Institute Hospital of the Japanese Foundation for Cancer Research;
Department of Internal Medicine Seoul National University Bundang Hospital Seoul National;
Samsung Medical Center Sungkyunkwan University;
Yonsei Cancer Center Yonsei University College of Medicine;
Department of Gastrointestinal Oncology Key Laboratory of Carcinogenesis and Translational;
Nanjing Bayi Hospital;
The First Affiliated Hospital Zhejiang University School of Medicine;
Department of Internal Medicine Cancer Research Institute Seoul National University College of;
AstraZeneca;
AstraZeneca;
AstraZeneca;
AstraZeneca;
AstraZeneca;
National Cancer Center Hospital;
机译:Olaparib与紫杉醇组合在患有先进的胃癌患者中,患有先进的胃癌(黄金):双盲,随机,安慰剂控制,第3期试验
机译:一项双盲,随机,安慰剂对照的2b期研究,评估索拉非尼联合紫杉醇作为HER2阴性晚期乳腺癌患者的一线治疗
机译:BOLERO-1:依维莫司联合曲妥珠单抗和紫杉醇作为一线治疗对HER2阳性(HER2 +),局部晚期或转移性乳腺癌的女性进行的随机,III期,双盲,安慰剂对照的依维莫司多中心试验公元前)
机译:I / II期临床试验关于每周紫杉醇(WPTX)和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
机译:鱼油(二十碳五烯酸和二十二碳六烯酸)对急性肺损伤患者的肺和全身炎症的II期,随机,双盲,安慰剂对照试验。
机译:Rilotumumab联合表柔比星顺铂和卡培他滨是晚期MET阳性胃或胃食管连接癌(RILOMET-1)的一线治疗:一项随机双盲安慰剂对照的3期临床试验
机译:依维莫司联合曲妥珠单抗加紫杉醇作为HER2阳性晚期乳腺癌患者(BOLERO-1)的一线治疗:3期,随机,双盲,多中心试验
机译:前列腺,双盲,并发,安慰剂对照临床试验静脉注射利巴韦林治疗肾综合征出血热